Amyloid β: one of three danger‐associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|15|3714-3727

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.15, 2015-08, pp. : 3714-3727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on amyloid-β homeostasis markers for sporadic Alzheimer's disease

By Zetterberg Henrik  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 1, 2009-02 ,pp. : 18-21

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer's disease associated with sporadic cerebral amyloid angiopathy in an elderly patient

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 6, 2015-06 ,pp. : 811-812

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Amyloid Treatments in Alzheimer's Disease

By  

Recent Patents on CNS Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 143-148

Bentham Science Publishers

Access to resources Recommend Favorite

SERUM PROTEINS, AMYLOID AND ALZHEIMER'S DISEASE*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 18, Iss. 10, 1970-10 ,pp. : 792-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 6, 2013-12 ,pp. : 905-913

John Wiley & Sons Inc

Access to resources Recommend Favorite